Article
Immune and stromal features of durable complete response to radiation and dual immune checkpoint blockade in pancreatic cancer
2026-08-10
Abstract excerpt
<h4>ABSTRACT</h4> Microsatellite stable (MSS) pancreatic ductal adenocarcinoma (PDAC) is refractory to immune checkpoint blockade. We conducted a single-arm phase II trial ( NCT04361162 ) combining nivolumab, ipilimumab and radiation therapy to treat patients with pre-treated metastatic MSS PDAC (n=30). We integrated longitudinal profiling of 32 pre- and on-treatment tumor biopsies from 22 patients, yielding 245...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 22044b4f-bd20-5b58-9d7e-09654cb1515c
- DOI
- 10.64898/2026.08.06.26359422
